JOA - 2026-11-01 - Journal Article
The Effects of Perioperative Intra-Articular Corticosteroids During Manipulation Under Anesthesia After Total Knee Arthroplasty: A Retrospective Study.
Ruberto RA, Dash A, Simmons S, Cooper HJ, Geller JA, Herndon CL
Topics
Key Takeaway
Intra-articular corticosteroid injection concurrent with MUA after TKA produced no significant improvement in ROM or PROMs at any time point through 12 months compared to MUA alone.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study asked whether adding intra-articular corticosteroid injection (CSI) to MUA after primary TKA improves ROM or patient-reported outcomes compared to MUA alone. In 103 MUAs performed by six surgeons from 2014–2023, ROM at 1, 3, 6, and 12 months and PROMs (WOMAC, SF-12, KSS) were equivalent between CSI and non-CSI groups. No infections or excess complications were attributable to CSI.
Key Limitation
Non-randomized CSI allocation by surgeon preference precludes causal inference, and the study is underpowered to detect small but clinically meaningful differences in ROM between groups.
Original Abstract
BACKGROUND
Postoperative stiffness after total knee arthroplasty (TKA) is uncommon, but may lead to major knee dysfunction. Manipulation under anesthesia (MUA) is an effective tool for improving postoperative stiffness. We hypothesized that intra-articular corticosteroid administration during MUA better preserves postmanipulation range of motion (ROM) compared to MUA without a glucocorticoid adjunct.
METHODS
A retrospective review of 103 MUAs by six arthroplasty surgeons at our institution from 2014 to 2023. Patients were included if they underwent MUA after a primary TKA for osteoarthritis or osteonecrosis and were excluded from analysis if they had bilateral MUA, MUA after revision TKA, or TKA for post-traumatic osteoarthritis. Patients were separated into groups based on whether they received a concurrent corticosteroid injection (CSI) during MUA. Age, sex, and time to MUA were similar between groups. Range of motion was assessed before MUA, intraoperatively following MUA, and at 1-month, 3-month, 6-month, and 1-year follow-up visits. Validated patient-reported outcome measures (PROMs) collected relative to initial TKA were assessed pre-MUA, and three months and one year after MUA. All patients were screened for complications and reoperations.
RESULTS
Compared to patients undergoing MUA without CSI, patients receiving CSI had similar improvement in ROM at one, three, six, and 12 months postmanipulation. There were similar improvements in PROMs between the groups, with the largest improvements observed at one year in Western Ontario and McMaster Universities Osteoarthritis Index pain and function, Short Form-12 physical, and Knee Society Score scores. Complications and reoperations were similar between the groups, and there were no infections associated with intra-articular CSI in our cohort.
CONCLUSIONS
The use of CSI concurrently with MUA was not associated with improved ROM or PROMs but demonstrated safety. The benefit of its use may be further elucidated by future randomized controlled trials.